Long before the opioid overdose crisis dominated headlines nationwide, Yale experts were advancing research and transforming the debate on this critical issue. More recently, Yale physicians were on the frontlines when a spike in overdose cases in New Haven signaled the need for an even more robust response from stakeholders across the state. From a variety of disciplines and areas of expertise, Yale faculty and researchers are reframing the problem of addiction and potential solutions.
Yale experts deliver state strategic plan to battle opioid epidemic
On Oct. 6, Yale's Schools of Medicine and of Public Health hosted a press conference convened by Connecticut Governor Dannel P. Malloy to receive the state’s final report and strategic plan on fighting the opioid epidemic.
Yale School of Public Health, Medicine experts join state fight against opioid epidemic
A team of experts from Yale’s schools of public health and medicine are partnering with the state of Connecticut to address an opioid epidemic that claimed hundred of lives last year. The Yale scientists will work on a strategic plan over the coming three months designed to reduce both the abuse of opioids and the number of overdoses.
Better quality of care may reduce risk of death for patients on long-term opioids
Better quality of care may reduce the risk of death for patients who are prescribed opioid painkillers for chronic pain, say Yale researchers. Their study offers evidence that supports recommendations from clinical practice guidelines encouraging physicians to engage patients with mental health services and substance abuse treatment.
Emergency department treatment for opioid addiction better than referrals
Yale researchers conducted the first known randomized trial comparing three treatment strategies for opioid-dependent patients receiving emergency care. They found that patients given the medication buprenorphine were more likely to engage in addiction treatment and reduce their illicit opioid use.
Research: Long-term use of prescription opioids linked to higher mortality
Taking prescription medications such as Vicodin or Oxycontin for long periods may increase a patient’s risk of death from any cause, according to Yale researchers. A Yale-led team found a strong association between long-term use of prescription opioids, as well as prescription benzodiazepines — a class of drugs often used to treat anxiety and insomnia — and death from all causes in patients.
Yale researcher approved for $12.4 million funding award to study veterans’ health
Dr. William Becker, assistant professor of medicine, has been approved for a $12.4 million funding award by the Patient-Centered Outcomes Research Institute to study pain management and opioid safety for veterans.
Yale researchers to participate in study of the genetics of ‘multi-substance use’ among veterans
A team of Yale researchers, together with Dr. Henry Kranzler of the Philadelphia VA Medical Center, have been awarded a grant from the Department of Veterans Affairs to study genetic and other data from the department’s Million Veteran Program. The program seeks to answer key questions on heart disease, kidney disease, and substance use — high-priority conditions affecting veterans.
For prescription drug addiction treatment, buprenorphine maintenance trumps detox
For treating patients with prescription opioid dependence in primary care,buprenorphine maintenance therapy is superior to detoxification, according to a new study by Yale School of Medicine researchers published in the Oct. 20 issue of JAMA Internal Medicine.
Yale leaders advance addiction medicine
Addiction has been increasingly recognized as a crisis in Connecticut and across the nation, but it has not always been viewed as a disease requiring evidence-based treatment like other medical specialties. That changed this week when the American Board of Medical Specialties announced that it would include addiction medicine as an official subspecialty.
Heroin in Connecticut’s Suburbs
Injection drug use, thought by many to be a problem of the inner cities, is prevalent and on the rise in even Connecticut’s most prosperous suburbs. But relatively little is known about this group of suburban drug users or their drug use habits, said Lauretta E. Grau, an associate research scientist at the Yale School of Public Health.
Yale scientist joins U.S. Nobel Conference to address addiction treatment
To speak to the topic of “Addiction: Exploring the Science and Experience of an Equal Opportunity Condition,” Yale School of Medicine’s Michael V. Pantalon joined a panel of experts at the 51st Nobel Conference at Gustavus Adolphus College in St. Peter, Minn. on Oct. 6-7.